| LANTHEUS HLDGS DL-,01 |
| USA |
| Gesundheit |
| US5165441032 / A117UE |
| 0L8 (Frankfurt) / LNTH (NASDAQ) |
| FRA:0L8, ETR:0L8, 0L8:GR, NASDAQ:LNTH |
| - |
| https://www.lantheus.com/ |
|
Lantheus Holdings, Inc. is a leading radiopharmaceutical-focused company that develops, manufactures, and commercializes diagnostic and therapeutic products to assist clinicians in diagnosing and treating heart disease, cancer, and other conditions w..
>Volltext.. |
| 4236.86 Mio. EUR |
| 4461.63 Mio. EUR |
| 1335.52 Mio. EUR |
| 330.34 Mio. EUR |
| 202.34 Mio. EUR |
| 2.99 EUR |
| 539.92 Mio. EUR |
| 311.11 Mio. EUR |
| 337.98 Mio. EUR |
| 1.08 |
| -11.42% |
| -34.11% |
| - |
| - |
| - |
| - |
| LANTHEUS |
| 05.04.26 |
|